National Psoriasis Foundation
Based in OR
🤖
AI Overview
With $1.2M in lobbying spend across 31 quarterly filings, National Psoriasis Foundation is a significant lobbying presence. Their lobbying covers 4 issue areas. Active from 2018 to 2025.
$1.2M
Total Spend
8
Years Active
1
Firms Hired
6
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $360K |
| 2019 | $280K |
| 2020 | $210K |
| 2021 | $144K |
| 2022 | $72K |
| 2023 | $66K |
| 2024 | $44K |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Medicare/Medicaid, Pharmacy
- •Urge Congress to support efforts that increase access to care for individuals living with psoriasis and psoriatic arthritis by supporting the Restoring the Patient's Voice Act (HR 2077). The bill refo
- •FY19 Appropriations for Psoriatic Disease
- •Allocate $1 million in the Fiscal Year 2019 Labor, Health and Human Services, Education and Related Agencies (LHHS) Appropriations bill to implement a public
- •In relation to the President's Drug Pricing Blueprint, the NPF advocated for patient priorities as they relate to potential Congressional proposals to move Medicare Part B drugs into Part D, adjust ou
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.